NCT06129006

Brief Summary

To compare ultrasound-guided shoulder anterior capsular infiltration plus hydrodilatation with a steroid versus hyalase in patients with frozen shoulders

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
6mo left

Started Nov 2023

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Nov 2023Dec 2026

First Submitted

Initial submission to the registry

November 8, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 13, 2023

Completed
12 days until next milestone

Study Start

First participant enrolled

November 25, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 24, 2025

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 5, 2026

Expected
Last Updated

November 13, 2023

Status Verified

November 1, 2023

Enrollment Period

1.5 years

First QC Date

November 8, 2023

Last Update Submit

November 8, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • The Shoulder Pain and Disability Index (SPADI)

    The Shoulder Pain and Disability Index (SPADI) will be used to evaluate pain and disability at baseline and 3 weeks, 3 months, and 12 months after the intervention

    baseline and 3 weeks, 3 months, and 12 months after the intervention

Study Arms (2)

group A shoulder anterior capsular infiltration plus hydrodilatation with steroids.

ACTIVE COMPARATOR

25 patients with frozen shoulders treated with ultrasound-guided shoulder anterior capsular infiltration plus hydrodilatation with steroids.

Procedure: hydrodilatation with steroid in group A versus hyalase in group B

groupB shoulder anterior capsular infiltration plus hydrodilatation with hyalase.

ACTIVE COMPARATOR

25 patients with frozen shoulders treated with ultrasound-guided shoulder anterior capsular infiltration plus hydrodilatation with hyalase.

Procedure: hydrodilatation with steroid in group A versus hyalase in group B

Interventions

Hydrodilatation technique: the ultrasound transducer will be placed on the posterior surface of the shoulder in the longitudinal plane to identify the posterior glenohumeral joint, bony glenoid, humeral head, and infraspinatus muscle.Then, after sterilizing the area to be injected, the needle will be advanced to the target point between the humeral head cartilage and the infraspinatus tendon using the ultrasound-guided in-plane technique.To ensure the injection into the glenohumeral joint, the Doppler mode will be used to confirm the widening of the space between the humeral cartilage and the innermost synovial line of the infraspinatus muscle by the injected solution.

group A shoulder anterior capsular infiltration plus hydrodilatation with steroids.groupB shoulder anterior capsular infiltration plus hydrodilatation with hyalase.

Eligibility Criteria

Age30 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with symptoms for more than three months but less than one year which has not improved with medications and physiotherapy.
  • aged 30 to 70 years old

You may not qualify if:

  • History of trauma to the shoulder.
  • History of fracture or dislocation around the shoulder.
  • Inflammatory arthritis
  • coagulation disorders
  • History of previous injections within three months.
  • Cervical radiculopathy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (7)

  • Konarski W, Pobozy T, Hordowicz M, Pobozy K, Domanska J. Current concepts of natural course and in management of frozen shoulder: A clinical overview. Orthop Rev (Pavia). 2021 Jan 28;12(4):8832. doi: 10.4081/or.2020.8832. eCollection 2020 Dec 31.

    PMID: 33585024BACKGROUND
  • Sam N, Yusuf I, Idris I, Adnan E, Haryadi RD, Hamid F, Usman MA, Johan MP, Zainuddin AA. A Case Series: Effect of Comorbidities on the Outcomes of Prolotherapy Injection for Frozen Shoulder Patients. Int Med Case Rep J. 2023 Apr 28;16:257-263. doi: 10.2147/IMCRJ.S407723. eCollection 2023.

    PMID: 37143964BACKGROUND
  • Cho CH, Bae KC, Kim DH. Treatment Strategy for Frozen Shoulder. Clin Orthop Surg. 2019 Sep;11(3):249-257. doi: 10.4055/cios.2019.11.3.249. Epub 2019 Aug 12.

    PMID: 31475043BACKGROUND
  • Prasetia R, Albana R, Herman H, Lesmana R, Chernchujit B, Rasyid HN. Ultrasound-Guided Suprascapular Nerve Block at Spinoglenoid Notch and Glenohumeral Joint Hydrodilation. Arthrosc Tech. 2022 Jun 14;11(7):e1233-e1238. doi: 10.1016/j.eats.2022.03.009. eCollection 2022 Jul.

    PMID: 35936858BACKGROUND
  • Albana R, Prasetia R, Primadhi A, Rahim AH, Ismiarto YD, Rasyid HN. The role of suprascapular nerve block in hydrodilatation for frozen shoulder. SICOT J. 2022;8:25. doi: 10.1051/sicotj/2022026. Epub 2022 Jun 14.

    PMID: 35699461BACKGROUND
  • Cravioto A, Reyes RE, Ortega R, Fernandez G, Hernandez R, Lopez D. Prospective study of diarrhoeal disease in a cohort of rural Mexican children: incidence and isolated pathogens during the first two years of life. Epidemiol Infect. 1988 Aug;101(1):123-34. doi: 10.1017/s0950268800029289.

    PMID: 3402544BACKGROUND
  • Lee JH, Choi EJ, Han SC, Chung HS, Kwon MJ, Jayaram P, Lee W, Lee MY. Therapeutic efficacy of low-dose steroid combined with hyaluronidase in ultrasonography-guided intra-articular injections into the shoulder for adhesive capsulitis. Ultrasonography. 2021 Oct;40(4):555-564. doi: 10.14366/usg.20199. Epub 2021 Feb 22.

    PMID: 34399045BACKGROUND

MeSH Terms

Conditions

Bursitis

Interventions

Steroids

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal Diseases

Intervention Hierarchy (Ancestors)

Fused-Ring CompoundsPolycyclic Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

November 8, 2023

First Posted

November 13, 2023

Study Start

November 25, 2023

Primary Completion

May 24, 2025

Study Completion (Estimated)

December 5, 2026

Last Updated

November 13, 2023

Record last verified: 2023-11